Add a fat source (nut butter, avocado)
Whether the additional weight loss at 12mg justifies the higher dose depends on individual tolerability and side effect burden
More serious but less common risks include pancreatitis, gallbladder problems including gallstones, kidney issues including acute kidney failure in patients who experience severe vomiting or diarrhea, changes in vision, low blood sugar especially when combined with other diabetes medications, and increased heart rate
The GHRH-analog component engages the GHRH receptor, elevating cAMP via Gs-coupled signaling
Despite similar glycemic control, the insulin group showed significant reduction in liver fat burden assessed radiologically (mean MRI-PDFF, liver volume, total liver fat index), whereas no significant change was detected in the liraglutide group [75]
The STEP trials demonstrated that semaglutide users lost between 10-22% of their starting body weight depending on the dose used, compared to less than 3% in placebo groups